Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back Pain

NCT03891264 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03891264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03891264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back Pain
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Terminated
Start date
November 13, 2019
Completion date
November 23, 2020
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

back pain, low